Assays for fungal infection
AssigneeRutgers, The State University of New Jersey
InventorsSteven Park, David S. Perlin
Life of this patent
Estimating the term…
Abstract
Methods and kits are described for testing for the presence or absence of any fungus in a sample. Examples of fungi that can be detected include, but are not limited to, those belonging to the genera Candida, Aspergillus and Pneumocystis. The methods include obtaining a sample suspected of containing fungal nucleic acid, including at least one universal region of fungal nucleic acid, and testing for the presence or absence in the sample of the at least one universal region of fungal nucleic acid. Samples may be biological or non-biological.
Claims5
A kit for testing for the presence or absence of at least one region of fungal nucleic acid characteristic of the species Candida tropicalis comprising SEQ ID NO:
- 30, the complement or transcript thereof, or a sequence having 80% or more sequence identity with SEQ ID NO:
- 30, the complement or transcript thereof, in a human clinical sample comprising a molecular beacon probe comprising SEQ ID NO:
- 33 and a pair of primers comprising SEQ ID NO:
- 31 and SEQ ID NO:
- 32.
A kit for testing for the presence or absence of at least one region of fungal nucleic acid characteristic of the species Candida parapsilosis comprising SEQ ID NO:
- 34, the complement or transcript thereof, or a sequence having 80% or more sequence identity with SEQ ID NO:
- 34, the complement or transcript thereof, in a human clinical sample comprising a molecular beacon probe comprising SEQ ID NO:
- 35 and a pair of primers comprising SEQ ID NO:
- 31 and SEQ ID NO:
- 32.
A kit for testing for the presence or absence of at least one region of fungal nucleic acid characteristic of the species Candida albicans comprising SEQ ID NO:
- 36, the complement or transcript thereof, or a sequence having 80% or more sequence identity with SEQ ID NO:
- 36, the complement or transcript thereof, in a human clinical sample comprising a molecular beacon probe comprising SEQ ID NO:
- 37 and a pair of primers comprising SEQ ID NO:
- 31 and SEQ ID NO:
- 32.
A kit for testing for the presence or absence of at least one region of fungal nucleic acid characteristic of the species Candida glabrata comprising SEQ ID NO:
- 38, the complement or transcript thereof, or a sequence having 80% or more sequence identity with SEQ ID NO:
- 38, the complement or transcript thereof, in a human clinical sample comprising a molecular beacon probe comprising SEQ ID NO:
- 39 and a pair of primers comprising SEQ ID NO:
- 31 and SEQ ID NO:
- 32.
A kit for testing for the presence or absence of at least one region of fungal nucleic acid characteristic of the species Candida krusei comprising SEQ ID NO:
- 40, the complement or transcript thereof, or a sequence having 80% or more sequence identity with SEQ ID NO:
- 40, the complement or transcript thereof, in a human clinical sample comprising a molecular beacon probe comprising SEQ ID NO:
- 43 and a pair of primers comprising SEQ ID NO:
- 31 and SEQ ID NO:
- 32, a pair of primers comprising SEQ ID NO:
- 41 and 42, or a combination thereof.
Dependencies are inferred from the claim text.